The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...
Study reveals a gap FDA approval AI radiology devices with only 29% undergoing clinical testing before clearance.
Beyond Tariffs: The Software Supply Chain Risks Every Medical Device Manufacturer Should Be Watching
By reframing security as an investment rather than a cost, MDMs can reduce risk exposure, improve compliance readiness, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback